Table 1.
Studies reporting hepatitis C virus (HCV) incidence in Iran.
| Author, year (citation) | Year of data collection | Study site | Population’s classification based on risk of HCV exposure | Population | Sample size at recruitment | Lost to follow-up | HCV sero-conversion risk (relative to total sample size) | Duration of follow-up |
|---|---|---|---|---|---|---|---|---|
| Pourmand, 200747 | 2002–04 | Hospital | Special clinical population | Renal transplant patients | 141 | 0 | 2.1% | 24 months |
| Jabbari, 200846 | 2005–06 | Hospital | High risk population | Hemodialysis patients | 70 | 0 | 4.3% | 18 months |
| Azarkeivan, 201245 | 1996–09 | Blood transfusion center | High risk population | Thalassemia patients | 307 | 0 | 6.8% | 168 months |
| Dolan, 201249 | 2007–08 | Rehab center | Intermediate risk population | Female drug users on methadone treatment | 78 | 38 | 2.5% | 7 months |
| Bahar, 200748 | 1998–01 | Hospital | Special clinical population | Impaired glucose tolerance patients | 560 | 0 | 0.71% | 36 months |